Summary
30 ml of aluminum hydroxide gel, administered 15 minutes before a single oral dose of aureomycin, markedly depressed the serum aureomycin levels in 10 subjects. The simultaneous use of these two drugs is contraindicated. 30 ml of carmethose given in the same manner had no demonstrable effect on the aureomycin level of the serum, and effectively diminished the gastrointestinal disturbances frequently occurring with aureomycin therapy.
Amphojel adsorbs aureomycin in vitro. It does not destroy or inactivate the latter, but it seems to hold it firmly, not permitting intestinal absorption. Carmethose does not adsorb aureomycin in vitro, and does not interfere with intestinal absorption.
Similar content being viewed by others
Bibliography
Ross, S., Schoenbach, E. B., Burke, F. G., Bryer, M. S, Rice, E. C. and Washington, J. A.: J. A. M. A., 138:1213–1216, 1948. Aureomycin therapy of Rocky Mountain spotted fever.
Schoenbach, E. B. and Bryer, M. S.: J. A. M. A., 139:275–280, 1949. Treatment of primary atypical pneumonia with aureomycin.
Seed, J.C. and Wilson, C.E.: Bull. Johns Hopkins Hosp., 86: 415–418, 1950. The effect of aluminum hydroxide on serum aureomycin concentrations after simultaneous oral administration.
Waisbren, B. A. and Hueckel, J. S.: Proc. Soc. Exp. Biol. & Med., 73:73–74, 1950. Reduced absorption of aureomycin caused by aluminum hydroxide gel (Amphojel).
Boger. W. P., Matteucci, W. V., Beatty, J. O. and Baganz, H. M.: J. Phila. Gen. Hosp. 1:3–7, 1950 Aureomycin plasma concentration influenced by aluminum hydroxide.
Bartholomew, L.G. and Nichols, D. R.: Proc. Mayo Clin., 25: 370–373, 1950. Use of milk to control vomiting caused by aureomycin.
Di Gangi, F. E. and Rogers, C.H.: J. Am. Pharm. Assoc, 38: 646–647, 1949. Adsorption studies of aureomycin hydrochloride on aluminum hydroxide gel.
Schneierson, S. S. and Toharsky, B.: J. Bact., 57:483–487, 1949. A method for the determination of aureomycin in the blood.
Brick, I. B.: Am. J. Digest. Dis., 16:315–319, 1949. Experiences with sodium carboxymethylcellulose as an antacid.
Necheles, H., Kroll, H., Bralow, S. P., and Spellberg, M. A.: Am. J. Dig. Dis., Jan. 1951. Peptic ulcer in man, Part IV. A new antacid made to meet requirements of antacid therapy. Chemical and laboratory work. Bralow, S. P., Spellberg, M. A., Kroll, H., and NecheleB, H.: A J. Dig. Dis., Jan 1951. Peptic ulcer in man. Part V. A new antacid, SCMC, made to meet requirements of antacid therapy. Clinical evaluation.
Author information
Authors and Affiliations
Additional information
Aided by the Nelson Morris Fund. The Departments are in part supported by the Michale Reese Recharch Foundation
Rights and permissions
About this article
Cite this article
Greenspan, R., Maclean, H., Milzer, A. et al. Antacids and Aureomycin. Amer. Jour. Dig. Dis. 18, 35–37 (1951). https://doi.org/10.1007/BF02876255
Issue Date:
DOI: https://doi.org/10.1007/BF02876255